Tin tức & Cập nhật
Xem bài viết Dược
Xem
Chỉ hiển thị Multimedia

OnabotulinumtoxinA as effective as, safer than pharmacotherapy for OAB
02 Oct 2025
bởiStephen Padilla
Women with refractory overactive bladder (OAB) may improve their symptoms by using either intradetrusor onabotulinumtoxinA or combined pharmacotherapy with solifenacin and mirabegron, suggests a study.
02 Oct 2025

Dose reduction does not limit efficacy of trastuzumab deruxtecan in MBC
01 Oct 2025
bởiStephen Padilla
Reducing the dose of trastuzumab deruxtecan (T-DXd) does not have any significant effect on real-world (rw) progression-free survival (PFS) or treatment-related toxicities among patients with metastatic breast cancer (MBC), as shown in a Singapore study.
01 Oct 2025







